These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
54 related articles for article (PubMed ID: 2687049)
21. The total rehabilitation of Graves' ophthalmopathy. DeSanto LW Laryngoscope; 1980 Oct; 90(10 Pt 1):1652-78. PubMed ID: 6893477 [TBL] [Abstract][Full Text] [Related]
22. Perspective--Part II: radiotherapy for Graves Orbitopathy: the Columbia University experience. Kazim M Ophthalmic Plast Reconstr Surg; 2002 May; 18(3):173-4. PubMed ID: 12021645 [No Abstract] [Full Text] [Related]
23. Does 131 I therapy for Graves' disease cause cancer? Hoffman DA; Lundin FE N Engl J Med; 1978 Sep; 299(12):662. PubMed ID: 581091 [No Abstract] [Full Text] [Related]
24. Probable risk of tumour induction after retro-orbital irradiation for Graves' ophthalmopathy. Snijders-Keilholz A; De Keizer RJ; Goslings BM; Van Dam EW; Jansen JT; Broerse JJ Radiother Oncol; 1996 Jan; 38(1):69-71. PubMed ID: 8850428 [TBL] [Abstract][Full Text] [Related]
31. [Radiotherapy in Graves; opthalmopathy is as effective as placebo-- this demonstration does not absolve other indications]. Klages HT Strahlenther Onkol; 2000 Nov; 176(11):536-7. PubMed ID: 11143530 [No Abstract] [Full Text] [Related]
36. [Effects of external orbital radiotherapy on the oculomotor muscle in Graves disease]. Maalouf T; Angioi-Duprez K; Beckendorff V; Malet T; George JL J Fr Ophtalmol; 1996; 19(12):748-54. PubMed ID: 9033899 [TBL] [Abstract][Full Text] [Related]
37. Role of orbital radiotherapy in the treatment of Graves' ophthalmopathy. Marcocci C; Bartalena L; Bogazzi F; Bruno-Bossio G; Pinchera A Exp Clin Endocrinol; 1991 May; 97(2-3):332-7. PubMed ID: 1915652 [No Abstract] [Full Text] [Related]